| dc.contributor.author | Humaira Zafar, Kiran Tauseef Bukhari, | |
| dc.contributor.author | Afroz S Kazi, Abdul Qadar Khan Mohmmand | |
| dc.date.accessioned | 2024-10-10T06:55:03Z | |
| dc.date.available | 2024-10-10T06:55:03Z | |
| dc.date.issued | 2012 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/18117 | |
| dc.description | Seniors Professor Dr. Humaira Zafar, BUCM, Department of Pathology | |
| dc.description.abstract | Hepatitis C is an infectious disease of viral origin primarily affecting the liver, caused by the hepatitis C virus (HCV).The infection is usually subclinical/ asymptomatic, but chronic infection can lead to scarring of the liver and ultimately to cirrhosis leading to liver failure, hepato cellular carcinoma or life-threatening esophageal and gastric varices. The route of acquiring infection is by an exposure to blood or blood products. The virus persists in the liver in about 85% of those infected patients. Persistent infection can be treated with various anti viral medications like peginterferon and ribavirin. Theseare amongstthe current standard therapy. Overall cure rate is between 51-80%. Those who develop cirrhosis or liver cancer may require a liver transplant, and the virus universally recurs after transplantation | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Isra Medical Journal | en_US |
| dc.subject | Viral Hepatitis C, Chronic Hepatitis, Subclinical Infection, Cirrhosis, Treatment | en_US |
| dc.title | An Overview of Hepatitis C Viral Infection and Its Management Options | en_US |
| dc.type | Article | en_US |